Bristol/Sanofi Receive FTC Subpoena Over Failed Plavix Settlement With Apotex
This article was originally published in The Pink Sheet Daily
Executive Summary
Both firms say they will comply with investigation seeking documents.
You may also be interested in...
Sanofi/Bristol Plavix Patent Suit To Begin Against Apotex
With preliminary injunction rulings weighing in Sanofi/Bristol's favor, Apotex's defense will need to make a strong case that clopidogrel patents are invalid.
Brand/Generic Settlements To Be Subject Of Senate Judiciary Hearing
PhRMA is among the parties scheduled to testify at the panel next week, which could coincide with the reintroduction of Sen. Kohl’s bill to curb settlements.
Plavix Sales Plummet With Generic Entry
Bristol estimates that “at risk” launch of generic clopidogrel impacted U.S. pharma sales by $525 mil. to $600 mil.